Federal Register / Vol. 74, No. 180 / Friday, September 18, 2009 / Notices 47929 

DEPARTMENT OF DEFENSE 

Department of the Army; Corps of 

Engineers 

Intent To Hold an Open Meeting of the 

North Dakota River Task Force 

Established by the Missouri River 

Protection and Improvement Act of 

2000 (Title VII) 

AGENCY: Department of the Army, U.S. 

Army Corps of Engineers, DoD. 

ACTION: Notice of meeting. 

SUMMARY: The duties of the Task Force 

are to prepare and approve a plan for 

the use of the funds made available 

under Title VII to promote conservation 

practices in the Missouri River 

watershed, control and remove the 

sediment from the Missouri River, 

protect recreation on the Missouri River 

from sedimentation, and protect Indian 

and non-Indian historical and cultural 

sites along the Missouri River from 

erosion. 

DATES: North Dakota Missouri River 

Task Force established by the Missouri 

River Protection and Improvement Act 

of 2000 will hold a meeting on October 

15, 2009, from 11 a.m. to 3 p.m. 

ADDRESSES: The meeting will be held at 

the Best Western Doublewood Inn 

located at 1400 E Interchange Avenue in 

Bismarck, North Dakota. 

FOR FURTHER INFORMATION CONTACT: 

Laura Bentley at (402) 995–2714. 

SUPPLEMENTARY INFORMATION: The 

objectives of the Task Force are to 

prepare and approve a plan for the use 

of the funds made available under Title 

VII, develop and recommend to the 

Secretary of the Army ways to 

implement critical restoration projects 

meeting the goals of the plan, and 

determine if these projects primarily 

benefit the Federal Government. 

This meeting is open to the public. 

Any interested person may attend, 

appear before, or file statements with 

the task force; however, statements and 

questions should be submitted in 

advance. For additional information, 

contact Laura Bentley, U.S. Army Corps 

of Engineers, 1616 Capitol Avenue, 

Omaha, NE 68102–1618, 402–995–2714. 

Brenda S. Bowen, 

Army Federal Register Liaison Officer. 

[FR Doc. E9–22551 Filed 9–17–09; 8:45 am] 

BILLING CODE 3720–58–P 

DEPARTMENT OF DEFENSE 

Department of the Army 

Advisory Committee Meeting Notice 

AGENCY: Department of the Army, DOD. 

ACTION: Notice of meeting. 

SUMMARY: Pursuant to the Federal 

Advisory Committee Act of 1972 (5 U. 

S. C., Appendix, as amended), the 

Sunshine in the Government Act of 

1976 (U. S. C. 552b, as amended) and 41 

Code of the Federal Regulations (CFR 

102–3.140 through 160), the Department 

of the Army announces the following 

committee meeting: 

Name of Committee: U.S. Army 

Command & General Staff College 

Subcommittee. 

Date: October 27–28, 2009. 

Place: US Army Command and 

General Staff College, Ft. Leavenworth, 

KS, Lewis & Clark Center, 66027. 

Time: 8:30 a.m. to 4 p.m. (October 27, 

2009). 8:30 a.m. to 12 p. m. (October 28, 

2009). 

Proposed Agenda: Starting point of 

the meeting will be an overview of the 

CGSC, as well as its constituent schools, 

the Command and General Staff School 

and the School of Advanced Military 

Studies. Subcommittee members will 

gather information from students, staff 

and faculty. General deliberations 

leading to provisional findings for 

referral to the Army Education Advisory 

Committee will follow on October 28, 

beginning at about 0900. 

FOR FURTHER INFORMATION CONTACT: For 

information, please contact Dr. Robert 

Baumann at 

robert.f.baumann@us.army.mil. Written 

submissions are to be submitted to the 

following address: U.S. Army Command 

and General Staff College 

Subcommittee, ATTN: Alternate 

Designated Federal Officer (Baumann), 

Lewis & Clark Center, U.S. Army 

Command and General Staff College, Ft. 

Leavenworth, KS 66027. 

SUPPLEMENTARY INFORMATION: Meeting of 

the Advisory subcommittee is open to 

the public. Attendance will be limited 

to those persons who have notified the 

Advisory Subcommittee Management 

Office at least 10 calendar days prior to 

the meeting of their intention to attend. 

Filing Written Statement: Pursuant to 

41 CFR 102–3.140d, the Committee is 

not obligated to allow the public to 

speak, however, interested persons may 

submit a written statement for 

consideration by the Subcommittees. 

Individuals submitting a written 

statement must submit their statement 

to the Alternate Designated Federal 

Officer (ADFO) at the address listed (see 

FOR FURTHER INFORMATION CONTACT). 

Written statements not received at least 

10 calendar days prior to the meeting, 

may not be provided to or considered by 

the subcommittees until its next 

meeting. 

The ADFO will review all timely 

submissions with the Chairperson, and 

ensure they are provided to the 

members of the respective 

subcommittee before the meeting. After 

reviewing written comments, the 

Chairperson and the ADFO may choose 

to invite the submitter of the comments 

to orally present their issue during open 

portion of this meeting or at a future 

meeting. 

The ADFO, in consultation with the 

Chairperson, may allot a specific 

amount of time for the members of the 

public to present their issues for review 

and discussion. 

Brenda S. Bowen, 

Army Federal Register Liaison Officer. 

[FR Doc. E9–22555 Filed 9–17–09; 8:45 am] 

BILLING CODE 3710–08–P 

DEPARTMENT OF DEFENSE 

Department of the Army 

Availability for Non-Exclusive, 

Exclusive, or Partially Exclusive 

Licensing of U.S. Provisional Patent 

Application Concerning Novel Use and 

Method of Rapamycin To Treat Toxic 

Shock 

AGENCY: Department of the Army, DoD. 

ACTION: Notice. 

SUMMARY: Announcement is made of the 

availability for licensing of the 

invention set forth in U.S. Provisional 

Patent Application Serial No. 61/ 

045,184 entitled ‘‘Novel Use and 

Method of Rapamycin to Treat Toxic 

Shock,’’ filed August 5, 2009. The 

United States Government, as 

represented by the Secretary of the 

Army, has rights to this invention. 

ADDRESSES: Commander, U.S. Army 

Medical Research and Materiel 

Command, ATTN: Command Judge 

Advocate, MCMR–JA, 504 Scott Street, 

Fort Detrick, Frederick, MD 21702– 

5012. 

FOR FURTHER INFORMATION CONTACT: For 

patent issues, Ms. Elizabeth Arwine, 

Patent Attorney, (301) 619–7808. For 

licensing issues, Dr. Paul Mele, Office of 

Research and Technology Assessment, 

(301) 619–6664, both at telefax (301) 

619–5034. 

SUPPLEMENTARY INFORMATION: The 

invention relates to the use of 

Rapamycin as a treatment of toxic shock 


erowe on DSK5CLS3C1PROD with NOTICES